BMS Decision to Lay Off 2,200 Employees Comes After M&A Spending Spree

By /

Is there a connection between Bristol Myers Squibb’s announcement that it will reduce its headcount by 6% and the company’s recent acquisitions of Karuna Therapeutics, Mirati and RayzeBio?

Scroll to Top